VANCOUVER, British Columbia, Jan. 23, 2019 (GLOBE NEWSWIRE) -- EnviroLeach Technologies Inc. (the “Company “or “EnviroLeach”), (CSE: ETI) (OTCQB: EVLLF) (7N2: FSE). is pleased to announce that it has shipped…
ENGLEWOOD, CO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Lightwave Logic, Inc. (OTCQB: LWLG), a technology company focused on the development of Next Generation Photonic Devices and Non-Linear Optical Polymer Materials Systemsfor…
Cyberfort Software, Inc. (OTC: CYBF) Embeds Security in Your Digital Devices Cybersecurity Challenges Climb with Rise of the IoT As Much as Smart Phones and PCs, Autonomous Digital Devices Are…
CEO Evan Gappelberg of NexTech AR Solutions Corp., talks about recent acquisition, using it as a platform for testing their technologies, and future growth of augmented reality.
CARLSBAD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based, clinical stage biotechnology company developing novel stem cell-based therapies…
DALLAS, TX, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – NaturalShrimp, Inc. (OTCQB: SHMP) said today that the joint patent it announced recently for the first commercially viable system…
Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBI to Service the $250…
FutPost.com Soccer Social Network Launches New Mobile App New app is a part of the company strategy to better connect MLS players, coaches, youth leagues and soccer fans together DENVER,…
CEO Mike Neylan of Cellcube Energy Storage Sys Inc., discusses vanadium deposit in Nevada, it's listing as a separate entity, and recent revenue growth.
BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem cell therapy technology SkinDisc WESTMINSTER, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE)…
Major Cancer Research Center Reports Pressure BioSciences' PCT Platform Could Play Major Role in Improving Cancer Diagnosis and Treatment Publication Cites Significant Benefits from Using the PCT Platform in the…
Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 19th at 4:30 PM EST Update to Include Discussions on Recent Progress, Accomplishments, and Enhancements in All Three Platform Technologies;…